voice search
Dacomitinib Tablet 45mg Recommended For: It Is Suitable For Patients With Non-small Cell Lung Cancer (Nsclc) Who Treat Epidermal Growth Factor Receptor (Egfr) 19 Exon Missing Mutation Or Exon 21 L858r Replacement Mutation

Dacomitinib Tablet 45mg Recommended For: It Is Suitable For Patients With Non-small Cell Lung Cancer (Nsclc) Who Treat Epidermal Growth Factor Receptor (Egfr) 19 Exon Missing Mutation Or Exon 21 L858r Replacement Mutation

Get Latest Price

In Stock

In Stock

Product Specifications

Physical FormTablets
Recommended ForIt is suitable for patients with non-small cell lung cancer (NSCLC) who treat epidermal growth factor receptor (EGFR) 19 exon missing mutation or exon 21 L858R replacement mutation
DosageThe recommended dose is 45 mg daily orally, once a day.
Storage InstructionsDry Place

Product Overview

Key Features

Common name:Daktini
Dosage form:Tablets
Wrap:30 tablets
Specification:45 mg
Origin:Elemental Pharmaceuticals

Company Details

Established in 2015, ELEMENTO PHARMA has made a name for itself in the list of top suppliers of Common Medicines & Drugs in India. The supplier company is located in Shanghai, Shanghai, and is one of the leading sellers of listed products.
ELEMENTO PHARMA is listed in Trade India's list of verified sellers offering supreme quality of 1mg Talazoparib Capsules, 200mg Capmatinib Tablets, 250mg Crizotinib Capsules, etc. Buy Common Medicines & Drugs in bulk from us for the best quality products and service.

Business Type

Exporter, Manufacturer, Distributor, Supplier, Trading Company

Employee Count

40

Establishment

2015

Working Days

To

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

4 RatingRating

Shanghai, Shanghai

Marketing Manager

Mr Yang Chen

Address

Room 618, Zhaojiabang Road 789, Xuhui District, Shanghai, Shanghai, 200000, China

pharmaceutical tablets in Shanghai

Report incorrect details

Compare With Similar Products

Buyer Feedback

4

Physical Form

Tablets

Tablet, Other

Tablets

Recommended For

It is suitable for patients with non-small cell lung cancer (NSCLC) who treat epidermal growth factor receptor (EGFR) 19 exon missing mutation or exon 21 L858R replacement mutation

Patients experiencing chronic or acute pain

Dosage

The recommended dose is 45 mg daily orally, once a day.

One tablet 2-3 times daily as directed by a physician

Storage Instructions

Dry Place

Store in a cool dry place away from direct sunlight and moisture.

Cool and dry place

People Also Viewed